Does APIXABAN Cause Lung neoplasm malignant? 411 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 411 reports of Lung neoplasm malignant have been filed in association with APIXABAN (ELIQUIS). This represents 0.3% of all adverse event reports for APIXABAN.
411
Reports of Lung neoplasm malignant with APIXABAN
0.3%
of all APIXABAN reports
148
Deaths
89
Hospitalizations
How Dangerous Is Lung neoplasm malignant From APIXABAN?
Of the 411 reports, 148 (36.0%) resulted in death, 89 (21.7%) required hospitalization, and 12 (2.9%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 411 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
FLUTICASONE\SALMETEROL (345)
Which APIXABAN Alternatives Have Lower Lung neoplasm malignant Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ